Article
Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and type 2 diabetes.
Pharmacogenomics - 1 Jun 2007
Seda Ondørej, Sedová Lucie
Abstract excerpt
The three isotypes of peroxisome proliferator-activated receptors (PPARs) are currently perceived as major regulatory nodes (or hubs) of metabolic pathway networks, linking most prevalent diseases including Type 2 diabetes, obesity, dyslipidemia and atherosclerosis. The integrative functions of PPARs are also reflected in their ecogenetic profile, when the variants underlying pharmacogenetic interactions were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
